Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

Yiling Pharma Warning Letter: Equipment

The U.S. Food and Drug Administration (FDA) has issued a Warning Letter in June 2025

Qvents
June 5, 2025

Biocon Malaysia USFDA 483 Cites Inadequa

Biocon Malaysia was inspected by USFDA Investigators Eileen A. Liu, Patty P. Kaewussdangkul, Daniel Lahar,

Qvents
August 16, 2023